CYAD Annual ROE
-932.48%
-868.99%-1368.70%
31 December 2022
Summary:
As of February 4, 2025, CYAD annual return on equity is -932.48%, with the most recent change of -868.99% (-1368.70%) on December 31, 2022. During the last 3 years, it has fallen by -876.58% (-1568.12%).CYAD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYAD Quarterly ROE
-80.41%
+2.82%+3.39%
30 June 2022
Summary:
As of February 4, 2025, CYAD quarterly return on equity is -80.41%, with the most recent change of +2.82% (+3.39%) on June 30, 2022. Over the past year, it has dropped by -23.42% (-41.09%).CYAD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYAD ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1368.7% | -41.1% |
3 y3 years | -1568.1% | -31.5% |
5 y5 years | -1017.7% | -239.3% |
CYAD ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -260.3% | +439.3% |
Celyad Oncology SA ROE History
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | -932.48%(+1368.7%) | - |
June 2022 | - | -80.41%(-3.4%) |
Mar 2022 | - | -83.23%(-13.6%) |
Dec 2021 | -63.49%(+44.2%) | -96.34%(+38.0%) |
Sept 2021 | - | -69.83%(+22.5%) |
June 2021 | - | -56.99%(+74.7%) |
Mar 2021 | - | -32.63%(-29.4%) |
Dec 2020 | -44.04%(-21.2%) | -46.23%(+210.1%) |
Sept 2020 | - | -14.91%(-79.7%) |
June 2020 | - | -73.57%(+23.7%) |
Dec 2019 | -55.90%(-23.7%) | -59.48%(-2.7%) |
June 2019 | - | -61.15%(-4.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | -73.28%(-12.2%) | -64.03%(-31.5%) |
June 2018 | - | -93.46%(+15.2%) |
Dec 2017 | -83.43%(+248.1%) | -81.12%(+242.3%) |
June 2017 | - | -23.70%(-2.3%) |
Dec 2016 | -23.97%(-42.8%) | -24.27%(-12.6%) |
June 2016 | - | -27.77%(-14.9%) |
Dec 2015 | -41.87%(-46.6%) | -32.63%(-18.5%) |
June 2015 | - | -40.05%(-34.6%) |
Dec 2014 | -78.45%(-58.5%) | -61.26%(-27.0%) |
June 2014 | - | -83.88%(-72.7%) |
Dec 2013 | -189.16%(-132.5%) | -307.73% |
Dec 2012 | 581.76%(-149.7%) | - |
Dec 2011 | -1170.40% | - |
FAQ
- What is Celyad Oncology SA annual return on equity?
- What is the all time high annual ROE for Celyad Oncology SA?
- What is Celyad Oncology SA annual ROE year-on-year change?
- What is Celyad Oncology SA quarterly return on equity?
- What is the all time high quarterly ROE for Celyad Oncology SA?
- What is Celyad Oncology SA quarterly ROE year-on-year change?
What is Celyad Oncology SA annual return on equity?
The current annual ROE of CYAD is -932.48%
What is the all time high annual ROE for Celyad Oncology SA?
Celyad Oncology SA all-time high annual return on equity is 581.76%
What is Celyad Oncology SA annual ROE year-on-year change?
Over the past year, CYAD annual return on equity has changed by -868.99% (-1368.70%)
What is Celyad Oncology SA quarterly return on equity?
The current quarterly ROE of CYAD is -80.41%
What is the all time high quarterly ROE for Celyad Oncology SA?
Celyad Oncology SA all-time high quarterly return on equity is -14.91%
What is Celyad Oncology SA quarterly ROE year-on-year change?
Over the past year, CYAD quarterly return on equity has changed by -23.42% (-41.09%)